A Danish monkeypox vaccine has been approved following WHO (World Health Organisation) declaring the current outbreak of the virus as a ‘global health emergency’.
In a statement released last Saturday, July 23, Tedros Adhanom Ghebreyesus, the head of the World Health Organisation, declared “I have decided that the global monkeypox outbreak represents a public health emergency of international concern.”
In the statement, he said, “the outbreak has continued to grow and we have now more than 16,000 reported cases from 75 countries and territories and five deaths”.
Following a review by an expert committee appointed by WHO to monitor the outbreak, it was decided that the risk posed by monkeypox globally is moderate except in Europe where they have determined the risk to be ‘high’.
Summarising the findings, Ghebreyesus said, “we have an outbreak that has spread around the world rapidly through new modes of transmission about which we understand too little”.
"For all of these reasons, I have decided that the global #monkeypox outbreak represents a public health emergency of international concern."-@DrTedros pic.twitter.com/qvmYX1ZBAL
— World Health Organization (WHO) (@WHO) July 23, 2022
Despite, the ‘moderate’ risk in countries outside Europe, the status of ‘global health emergency’ sees the virus receiving the highest warning which has only been declared on seven other occasions since 2009, most recently during the Covid-19 pandemic.
It is hoped that the WHO declaration will increase investment in vaccines and treatments of the disease which to date has disproportionately affected gay, bisexual men, and men who have sex with men.
Following the health organisation’s status upgrade to ‘global health emergency’, Bavarian Nordic, a Danish biotechnology company announced that the European Medicines Agency has granted permission for its Imvanex vaccine to be administered for monkeypox.
Bavarian Nordic receives positive CHMP opinion on the extension of vaccine label to include #monkeypox https://t.co/T6Vz57JaFo
— Bavarian Nordic (@BavarianNordic) July 22, 2022
Whilst the vaccine has been in circulation for some time as a treatment for smallpox until now in Europe it has only been administered for “off-label” use. The Imvanex vaccine was also awarded approval as a preventative for monkeypox in the US and Canada earlier this month.
With organisations such as ACT UP Dublin calling upon the HSE to provide a vaccination programme, hopefully, the EU approval we speed up the process.
© 2022 GCN (Gay Community News). All rights reserved.
GCN has been a vital, free-of-charge information service for Ireland’s LGBTQ+ community since 1988.
During this global COVID pandemic, we like many other organisations have been impacted greatly in the way we can do business and produce. This means a temporary pause to our print publication and live events and so now more than ever we need your help to continue providing this community resource digitally.
GCN is a registered charity with a not-for-profit business model and we need your support. If you value having an independent LGBTQ+ media in Ireland, you can help from as little as €1.99 per month. Support Ireland’s free, independent LGBTQ+ media.
comments. Please sign in to comment.